{"id":"W4407762805","doi":"10.1016/j.ahj.2025.02.011","title":"Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS)","year":2025,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Janssen Research and Development; Bristol-Myers Squibb; Bristol-Myers Squibb Foundation","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Cardiology; Intensive care medicine; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006668679,0.001202975,0.001632141,0.0005518584,0.0008038729,0.001306487,0.001533445,0.002083267,0.006974973],"category_scores_gemma":[0.004850364,0.0005896571,0.001345997,0.0005190483,0.001283103,0.0009298446,0.0007643127,0.003241933,0.001784372],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006786971,"about_ca_system_score_gemma":0.004013394,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004020544,"about_ca_topic_score_gemma":0.001172474,"domain_scores_codex":[0.9979905,0.001335944,0.0001063559,0.0001818589,0.0001980165,0.000187386],"domain_scores_gemma":[0.9982406,0.0003521878,0.0003191026,0.000186445,0.0002703234,0.0006312634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.6777333,0.04159006,0.006459755,0.006608312,0.001985762,0.0007422337,0.0005694019,0.003515686,0.0185703,0.009393793,0.04136597,0.1914654],"study_design_scores_gemma":[0.8315538,0.1186411,0.003295365,0.0006121153,0.001077208,0.0003845611,0.0000734295,0.00152639,0.002613304,0.002534388,0.03762459,0.00006367284],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.427556,0.02452892,0.02260512,0.014407,0.003430741,0.4716668,0.009395688,0.0009217667,0.02548786],"genre_scores_gemma":[0.5248082,0.01056286,0.05028901,0.01625904,0.001714335,0.3841358,0.005196058,0.0001325423,0.00690223],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.006974973,"threshold_uncertainty_score":0.03526771,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02667828341981661,"score_gpt":0.3127346481185014,"score_spread":0.2860563646986848,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}